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ABSTRACT
 
DNA damage occurs in many settings, including normal replication and exposure to 
radiation. Branched DNA structures such as Holliday junctions (HJs) and 5’ flaps are 
important intermediates formed in the process of DNA repair, and H. sapiens GEN1 is a 
nuclease that can repair these intermediates. In vitro, human GEN1 and the structurally 
similar Drosophila melanogaster GEN (DmGEN) cleave 5’ flaps more efficiently than 
HJs. Substrate specificity is thought to be determined by a helical arch region, adjacent 
to the active site, through which ssDNA may be threaded for cleavage. Homologs of 
GEN have variable arch regions, and thus different substrate specificities— while 
DmGEN has specificity for HJs, 5’ flaps, and replication forks, its ortholog from C. 
thermophilum (CtGEN1) lacks the arch region, and thus is limited to HJ activity. 
Conversely, its homolog found in H. sapiens (HsFEN1) exhibits specificity for 5’ flaps 
due to a different arch region. To manipulate the substrate specificity of DmGEN, I 
replaced the arch region with the corresponding region from both CtGEN1 and HsFEN1 
to yield two chimeric proteins termed GEN[CtGEN1] and GEN[HsFEN1]. I hypothesized that 
GEN[CtGEN1] would have specificity to only HJs and GEN[HsFEN1] would have specificity 
only to 5’ flaps. Nuclease assays revealed that neither GEN[CtGEN1] nor GEN[HsFEN1] was 
able to cleave HJs, suggesting that the swapped region plays a role in substrate binding 
or cleavage. Further research, including 5’ flap nuclease assays and in vivo 
experiments, is needed to better understand the consequences of only cleaving 5’ flaps 
or HJs in DNA repair. Ultimately, this work will offer novel insights into the role of the 
DmGEN nuclease including its substrate specificity in isolation and in the greater 






















DNA is routinely damaged by factors such as UV radiation, carcinogens, errors in the 
normal replication pathway, and recombination. If damage persists, cells may undergo 
apoptosis or exhibit cancerous growth, two fates that can be catastrophic. During 
normal DNA repair in response to damage, branched DNA structures are formed, such 
as Holliday junctions (HJs), 5’ flaps, splayed arms, and forked structures that serve as 
intermediates (Holliday 1964; Ishikawa et al. 2004; Kanai et al. 2007; Ip et al. 2008). A 
unique class of nucleases termed structure-specific endonucleases is responsible for 
cleaving and thus resolving these branched DNA intermediates. Drosophila 
melanogaster GEN (DmGEN) is an endonuclease shown to have affinity for HJs and is 
thus termed a HJ resolvase (Ip et al. 2008). In vitro studies have shown that DmGEN 
and its human ortholog are also able to resolve branched and forked structures that 
arise in the DNA damage repair process (Ip et al. 2008; Chan and West 2015; Bellendir 
et al. 2017). 
 
Though the activity of H. sapiens GEN1 is important in the DNA repair pathway, it has 
been shown that GEN functions secondarily to Mus81 in humans and yeast (Blanco et 
al. 2010; Tay and Wu 2010; Muñoz et al. 2012; Sarbajna et al. 2014). This relationship 
is reversed in Drosophila melanogaster; Gen mutants exhibit more sensitivity to 
damaging agents than mus81 mutants, suggesting that DmGEN assumes a primary 
role in resolving damaged DNA (Andersen et al. 2011; Bellendir et al. 2017). While it 
was previously understood that the main function of DmGEN was as a HJ resolvase (Ip 
et al. 2008), our lab has recently shown that in vitro, both human and Drosophila GEN 
act more efficiently on 5’ flaps, a ssDNA substrate (Bellendir et al. 2017; Figure 1). The 
contradiction between the recent biochemical data and the genetic data sparks an 
interesting question: what is the most critical DNA intermediate to resolve in vivo? 
Drosophila melanogaster is a useful model in which to answer this due to its use of 
DmGEN as a primary enzyme in DNA repair. Because DmGEN is primary and cleaves 
5’ flaps most effectively, we hypothesize that resolving these simpler branched 
structures may be the more biologically important activity of GEN and its orthologs in 
repairing damaged DNA. 
 
Figure 1. HJ and 5’ flap substrates.  
Blue arrows correspond to the site of cleavage by 
GEN and homologous nucleases. On the HJ 
substrate, cleaving across the other diagonal is 




Interestingly, the substrate specificity of GEN homologs varies depending on the 
organism. This inconsistency can be attributed to a highly variable region within 
residues 76-151 of GEN homologs (Tomlinson et al. 2010; Bellendir et al. 2017; Figure 
2). This region corresponds to an arch in the protein, which is adjacent to its active site 
(Lee et al. 2015; Liu et al. 2015). This arch is thought to be responsible for threading 
ssDNA through for better cleavage (Ceska et al. 1996; Patel et al. 2012). DmGEN has 
the arch, yet is able to act on HJs, 5’ flaps, replication forks, and splayed arms (Kanai et 
al. 2007; Bellendir et al. 2017). Its ortholog C. thermophilum GEN1 (CtGEN1) acts 





region (Lilley 2017; Figure 3). Its structurally similar homolog found in H. sapiens, 
HsFEN1, plays a similar role in damage repair, yet shows specificity for 5’ flaps (Patel et 
al. 2012). While HsFEN1 has an arch, it is structured differently than that of DmGEN1 
and thus exhibits 5’ flap substrate specificity (Rass et al. 2010; Tsutakawa et al. 2011; 
Patel et al. 2012).  
 
 
Figure 2. Protein sequence alignment of DmGEN, HsFEN1, and CtGEN1 
The amino acids highlighted in blue, red, and orange represent the arch region 
swapped out of DmGEN and replaced with that of either HsFEN1 or CtGEN1. Note the 
large stretch of amino acids that is missing in CtGEN1—this corresponds to it lacking 






















Figure 3. Protein overlay of DmGEN and CtGEN1 
Pymol generated overlay of CtGEN1 (PDB: 5CNQ) crystal structure with PHYRE 
generated protein model of DmGEN. DmGEN (light pink) and CtGEN1 (fuchsia). The 








We aim to further investigate the substrate specificity of DmGEN and its role in DNA 
damage repair. We proposed to alter its substrate specificity from HJs, 5’ flaps, and 
forked DNA to solely HJs or 5’ flaps in two separate experiments. In doing so, we 
effectively “limited” the DNA intermediates DmGEN acts on. This was done by replacing 
a 60-residue span of DmGEN (its arch region) with the corresponding regions from 
CtGEN1 and HsFEN1 in two separate experiments. By doing so, the two chimeric 
proteins are expected to exhibit altered substrate specificities; the protein with the 50-
residue region from CtGEN1 (termed GEN[CtGEN1]) is expected to show specificity for 
HJs, and the protein with the region from HsFEN1 (termed GEN[HsFEN1]) is expected to 
show specificity for 5’ flaps. We hypothesize that altering this crucial region is sufficient 
to alter the substrate specificity of GEN and allow us to isolate its activity on one 
substrate or the other in the context of WT DmGEN. 
  
Here, we show purified GEN[HsFEN1] and GEN[CtGEN1] with an altered substrate specificity 
from that of WT DmGEN. However, instead of acting only on HJs, the chimeric 
GEN[CtGEN1] does not show specificity for HJs in vitro. As hypothesized, GEN[HsFEN1] also 















A. Plasmid construction 
Both GEN[CtGEN1] and GEN[HsFEN1] were created using IDT gBlocks® Gene Fragments to 
synthesize the sequences from CtGen1 and HsFen1. These sequences were first 
codon-optimized for expression in bacterial cells using the IDT Codon Optimization 
Tool; E. coli are biased towards certain codons, so this was taken into account for both 
fragments, as they would eventually be expressed in E. coli. The sequences were 
inserted into the parental vector pET21b-tr-Gen-His, which contains a truncated and 
more stable DmGen (1-518 amino acids), as well as a hexahistidine tag used in 
purification (Bellendir et al.  2017; Figure 4). pET21b-tr-Gen-His was linearized using 1 
U each of SmaI and MfeI. The CtGen1 and HsFen1 sequences were amplified via PCR 
using primers with overhangs complementary to the restriction enzyme sites SmaI and 
MfeI in the pET21b-tr-Gen-His vector. The sequences were then inserted into the linear 
pET21b-tr-Gen-His using In-Fusion cloning. Once verified by restriction enzyme digest, 
5 µL of pET21b-tr-Gen-His-CtGEN1 and 5 µL of pET21b-tr-Gen-His-HsFEN1 were 
transformed into Mach1 chemically competent E. coli cells for DNA amplification. The 
transgenic DNA was purified through alkaline lysis. The plasmids were verified using 1 




             
Figure 4. Plasmid construction 
Plasmid representations of the wild type DmGen (left) from pET21b-tr-Gen-His used as 
a template, as well as the transgenic plasmids containing DmGen[CtGEN1] (orange) and 
DmGen[HsFEN1] (red). The sequence for CtGen1 is slightly smaller than that of HsFen1, 
corresponding to its lacking the arch region. Generated using Plasmidomics 0.2. 
 
 
B. Protein expression 
5 µL of plasmids containing DmGen[CtGEN1] and DmGen[HsFEN1] were each transformed 
into 50 µL Rosetta pLysS E. coli bacterial cells (Novagen), which are optimized for 
eukaryotic protein expression. The cells were heat shocked at 42°C for 30 seconds and 
allowed to recover on ice for 30 minutes. Following recovery, 500 µL Luria Broth (LB) 
media was added to each transformation tube and left to shake for 1 hour incubated at 
37°C. 300 µL of the transformation reactions were plated on ampicillin plates. After 
overnight growth at 37°C, one colony of each transformation reaction was isolated for 
incubation in 10 mL LB shaking for 16 hours at 37°C. All 10 mL of each overnight 
culture was added to two separate beveled flasks containing 1 L LB and 1 mL ampicillin 
resistance each for large-scale expression. Both 1 L flasks were incubated, shaking at 
37°C for 4 hours until the optical density (OD600) reached 0.4. The OD600 measures the 
absorbency of the bacteria at 600 nm wavelength, which thus indicates its 
concentration. The temperature of the incubator was then turned down to 18°C, allowing 
the temperature to slowly get cooler and reach 18°C when the OD600 was at 0.72 for the 
bacteria expressing GEN[CtGEN1]  and 0.8 for GEN[HsFEN1]. An OD600 within a range of 0.6-
0.8 indicates that the bacteria have reached a density optimal for protein expression 
induction. To induce protein expression, 0.01 mM of IPTG was added to each 1 L flask. 
IPTG activates the lac operon, which drives expression of proteins in the Rosetta pLysS 
cells, thus expressing the chimeric proteins. Both cells expressed at 18°C for 18 hours. 
After 18 hours, the cells were spun down at 4500 RPM at 4°C for 30 minutes. The 
supernatant was discarded, and the cell pellets were frozen at -20°C until protein 
purification. 
 
C. Protein purification 
GEN[HsFEN1] and GEN[CtGEN1] were purified separately using the same protocol for each 
(Bellendir et al. 2017). The N-terminal hexahistidine tag on GEN[HsFEN1] and GEN[CtGEN1] 
has an imidazole side with an affinity for Ni+2, so the tagged proteins were first passed 
through a nickel column. GEN[HsFEN1] and GEN[CtGEN1] were resuspended in NiA buffer 
(20 mM KH2PO4 pH7.0, 100 mM ammonium acetate, 1mM DTT, 500 mM NaCl, 50 mM 
imidazole) and sonicated to break open the cell membrane, making the proteins 
accessible for purification. The supernatant was loaded onto a 5mL HisTrap HP column 
(GE Healthcare Life Sciences, Pittsburgh, PA). They were then eluted off the column 
using NiB buffer (20 mM KH2PO4 pH 7.0, 100 mM ammonium acetate, 1 mM DTT, 500 
mM NaCl, 500 mM imidazole). For ion exchange purification, a 6 mL Resource S 
column (GE Healthcare Life Sciences) was first equilibrated with MonoSA buffer (20 
mM KH2PO4 pH 7.0, 100 mM ammonium acetate, 1 mM DTT, 50 mM NaCl). The peak 
eluted proteins from the HisTrap HP column were diluted to 50 mM in NiA buffer without 
salt (20 mM KH2PO4 pH 7.0, 100 mM ammonium acetate, 1 mM DTT) and loaded onto 
the cation exchange column. The pI measurements of GEN[HsFEN1] and GEN[CtGEN1]  are 
8.9 and 8.6, respectively (compared to a pI from WT tr-GEN of 8.83). Because the pI of 
both chimeric proteins is greater than the pH of the buffer (7.0), the protein is positive in 
solution and thus the cation column was used. The proteins that bound to the cation 
column were eluted with increasing MonoSB (20 mM KH2PO4 pH 7.0, 100 mM 
ammonium acetate, 1mM DTT, 1 M NaCl). The peak fractions were added to a 
Superdex S200 column (GE Healthcare Life Sciences) for size exclusion 
chromatography. GEN[CtGEN1] and GEN[HsFEN1] were eluted using S200 buffer (50 mM 
HEPES, 400 mM NaCl, 100 mM ammonium acetate, 1 mM DTT) and frozen for storage 
at -80°C. 
 
D. Western Blot 
100 and 250 ng concentrations of GEN[CtGEN1] and GEN[HsFEN1] were run on an SDS-
PAGE and transferred overnight to the membrane at 4°C. The membrane was 
incubated with the primary antibody (rabbit-α-GEN, 1:40,000 dilution) at 25°C for 1 hr. 
The membrane was washed for 1 hr with 1X PBST. The secondary antibody (α-rabbit-
goat, 1:5,000 dilution) was added and incubated with the membrane for 45 minutes 
shaking at 25°C. After washing in 1X PBST, the membranes were exposed to 1 mL of a 
chemiluminescent substrate for detection (ThermoFisher SuperSignal 
Chemiluminescent Substrates). The membrane was exposed to film for 1 second and 
subsequently developed (Figure 6). 
E. Nuclease Assay 
Purified GEN[CtGEN1] and GEN[HsFEN1], as well as WT tr-DmGEN as a positive control 
were each diluted to 2 µM, and fluorescently-labeled HJ substrate was diluted to 229 
nM (WT DmGEN and HJ substrate gifts of Matthew Satusky). The three proteins were 
incubated in three separate 21 µL reactions each containing 90% Master HJ Mix [30% 
glycerol, 8.14 µL reaction buffer (50 mM Tris pH 8, 100 ug/mL BSA, 1mM DTT, 50 mM 
KCl, 5 mM MgCl2)] and 1% HJ substrate (229 nM) and allowed to react. Time points of 
the reactions were taken at 0, 10, 30, 60, 120, 300, and 600 seconds following initial 
incubation. The reactions were stopped by removing 3 µL aliquots of each and mixing 
with 6 µL deproteinization buffer (1.25 mg/mL ProK, 1.25% SDS, 62.5 mM EDTA). After 
15 minutes of deproteinization, 9 µL of loading buffer was added to the 9 µL of 
deproteinized reactions, and all 18 µL were loaded onto an 8% native gel and allowed to 





Purified GEN[CtGEN1] and GEN[HsFEN1] are expected sizes 
It remains unknown whether the arch region is sufficient to confer substrate specificity to 
DmGEN and its homologs. In attempt to investigate this, the helical arch region of 
DmGEN was swapped out and replaced with the corresponding regions from CtGEN1 
and HsFEN1. To validate the sizes, an SDS-PAGE of the purified proteins was first run. 
Wild-type truncated DmGEN is ~58 kDa (Bellendir et al. 2017), so because GEN[CtGEN1] 
lacks the arch, it is slightly smaller at 56 kDa. Conversely, GEN[HsFEN1] is slightly larger 
than WT truncated DmGEN at 60 kDa. The SDS-PAGE demonstrates the expected 
sized bands of GEN[CtGEN1] and GEN[HsFEN1] (Figure 5). Notable in Figure 5 are the very 
faint bands underneath each darker top band. Those most likely correspond to 
degraded protein, which would still be GEN and thus not eliminated by the purification 
steps. 
Figure 5. SDS-PAGE of GEN[CtGEN1] 
and GEN[HsFEN1] 
Both chimeric proteins on a 12% SDS-
PAGE with increasing concentrations 
stained with Coomassie. GEN[CtGEN1] is 
about 56 kDa in size and GEN[HsFEN1] is 




GEN[CtGEN1] and GEN[HsFEN1] are visible on western blot 
To ensure that the proteins seen in Figure 5 are in fact GEN, an antibody to GEN was 
used to perform a western blot. In both lanes with 250 ng of loaded protein, as well as 
the lane containing 100 ng of loaded GEN[HsFEN1] , there are visible degradation products 
to which the GEN antibody bound, confirming that the faint lower band in the SDS-
PAGE is indeed GEN. Nuclease-dead versions of WT tr-DmGEN have been made 
according to this protocol, and have confirmed that all activity is due to the mutated 
protein, in our case GEN[CtGEN1] or GEN[HsFEN1] (Bellendir et al. 2017). The degradation 
products are about 30 and 40 kDa in size for GEN[HsFEN1] and about 40 and 53 kDa for 
GEN[CtGEN1]. The difference between the two concentrations of loaded protein in the 




























concentrations of GEN[CtGEN1], as the GEN[HsFEN1] 250 ng sample is much more 
overexposed. Nevertheless, this western confirms the presence of purified GEN[HsFEN1] 
and GEN[CtGEN1], and explains the lower bands present on the SDS-PAGE gel are due to 
degradation product. 
 
Figure 6. Western blot of GEN[HsFEN1] and 
GEN[CtGEN1]. 
The western blot of GEN[HsFEN1] and GEN[CtGEN1]. 
Full- length products are visible at ~60 kDa and 
~56 kDa for GEN[HsFEN1] and GEN[CtGEN1], 
respectively. Degraded product is visible at ~30 
and ~40 kDa for GEN[HsFEN1] and ~40 and ~53 




Nuclease assay reveals GEN[HsFEN1] and GEN[CtGEN1] inactivity on HJs 
A nuclease assay was used to test the activity of GEN[CtGEN1] and GEN[HsFEN1] in vitro on 
the HJ substrate (provided by Matthew Satusky). Wild-type DmGEN cleaves HJs 
bidirectionally and thus yields three products; as the intact HJ decreases in 
concentration, the three fluorescently-labeled products increase in concentration (Panel 
A, Figure 7). These bands are not observed with GEN[HsFEN1] or GEN[CtGEN1] – the lower 
three HJ products are notably absent while the intact HJ remains constant, indicating 










































Figure 7. Nuclease assay for in vitro Holliday junction activity 
Above, nuclease assay with representation of tagged Holliday junction and in panel A, 
possible cleavage products. Panels B and C show no observable activity of the chimeric 
proteins on the HJ substrate. Note: the 10-second timepoint in panel A lacks observable 
data and this is most likely due to the reaction being loaded incorrectly or not at all. 
 
 
DISCUSSION AND CONCLUSION 
 
The importance of HJ versus 5’ flap substrate resolution in vivo still remains unknown in 
DNA damage repair. Here, we used Drosophila melanogaster GEN to test this due to its 
role as the primary enzyme in the repair pathway (Andersen et al. 2011, Bellendir et al. 
2017). Two DmGEN-based chimeric proteins were generated, which were predicted to 
have altered substrate specificity. In vitro, these proteins were hypothesized to act on 
either HJs or 5’ flaps in vitro. Our in vitro nuclease assays reveal that both chimeric 
proteins, GEN[HsFEN1] and GEN[CtGEN1], do not show HJ activity. This is to be expected for 
GEN[HsFEN1], due to its arch region conferring specificity for 5’ flap substrates. However, 











































































host organism’s CtGEN1. Yet, the chimeric protein  GEN[CtGEN1] does not have 
observable activity on HJs in this assay. 
 
This could be attributed to a number of factors. While CtGEN1 is structurally similar to 
DmGEN, it lacks the arch region and thus is limited to the four-way branched junctions 
(Lilley 2017). We hypothesized that swapping just the ~50 residue region from CtGEN1 
into the arch region of DmGEN (and thus eliminating DmGENs arch region) would be 
sufficient to confer the HJ substrate specificity of CtGEN1. However, it is possible that 
the active site or protein structure of the host protein is necessary for substrate binding 
or cleavage; the arch region of CtGEN1 may not exhibit HJ specificity outside of the 
context of the CtGEN1 protein. It is also possible that in changing that portion of the 
protein, we inhibited certain interactions responsible for protein dimerization on HJs, the 
proteins were unable to dimerize, and thus unable to act on HJs (Bellendir et al. 2017). 
It is unlikely that protein denaturation is causing the inactivity of GEN[CtGEN1], as it was 
handled the same as WT DmGEN throughout the experiment. 
 
Future goals include testing the protein activity on 5’ flaps and in vivo experiments. The 
5’ flap in vitro nuclease assays will also be tested using fluorescently-labeled substrates 
as was done to test for HJ specificity. We hypothesize that GEN[HsFEN1] will have activity 
on 5’ flaps and appear similar to the DmGEN control, as DmGEN can also cut flapped 
substrates. We do not expect to see GEN[CtGEN1] activity on 5’ flaps because this  protein 
should not have the arch used for threading flapped DNA through. 
Assuming that GEN[HsFEN1] acts on 5’ flaps in vitro, this protein will be a useful tool in 
vivo in Drosophila melanogaster. It will allow us to investigate consequences or benefits 
of having substrate specificity for solely flapped structures. Endogenous GEN will be 
replaced with the codon-optimized chimeric protein. Flies expressing GEN[HsFEN1] will be 
treated with DNA damaging agents to test for sensitivity and compared to flies with wild-
type GEN given the same DNA damaging treatments. If GEN[HsFEN1] acts solely on 5’ 
flaps and is able to rescue to wild-type levels after DNA damage, it is indicative of 5’ 
flaps being the more important substrate to resolve in vivo.  
 
Branched structures are critical intermediates in DNA damage repair, as their proper 
resolution leads to successful DNA reparation, replication, and cell growth. 
Understanding the endonucleases that resolve these intermediates is central to our 
knowledge of DNA repair. Using D. melanogaster is particularly helpful, as DmGEN 
assumes a primary role as an endonuclease, and as such, cuts 5’ flaps more efficiently 
than HJs. This indicates that the resolution of flaps (or simpler DNA lesions) is the more 
critical function of GEN in DNA repair, which can be tested by in vitro nuclease assays 
and in vivo sensitivity assays. We hope to gain novel insights into the role of this 
endonuclease, the substrates it preferentially cleaves, and how this activity can be 
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